Approaches to the immunological monitoring of cancer patients treated with natural or recombinant interferons.
D004341:Drug Evaluation; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000187:drug effects; D008221:Lymphoid Tissue / Q000166:cytology; D009000:Monocytes / Q000187:drug effects; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012107:Research Design
D007372:Interferons